PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pathology, New York University-Grossman School of Medicine , New York, NY, USA.\', \'Palisades Therapeutics/Pop Test Oncology LLC , Cliffside Park, NJ, USA.\', \'Department of Biology, Central State University , Wilberforce, OH, USA.\', \'Department of Urology and the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai , New York, NY, USA.\', \'Department of Medicine, New York University-Grossman School of Medicine , New York, NY, USA.\', \'Department of Animal, Dairy, and Veterinary Sciences, Utah State University , Logan, UT, USA.\', \'ADME Solutions, Inc , San Diego, CA, USA.\', \'Van Drie Research , North Andover, MA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/15384101.2020.1859752
?:hasPublicationType
?:journal
  • Cell cycle (Georgetown, Tex.)
is ?:pmid of
?:pmid
?:pmid
  • 33305659
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Clinical stage molecule PT150 is a modulator of glucocorticoid and androgen receptors with antiviral activity against SARS-CoV-2.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33305659>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33305659>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all